Matthew Ritter

Title: The Innovations of Matthew Ritter

Introduction

Matthew Ritter is an accomplished inventor based in Cypress, CA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic proteins. With a total of 2 patents, Ritter's work focuses on innovative solutions for preventing metastasis in cancer treatment.

Latest Patents

Ritter's latest patents include "Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions." Contortrostatin is a homodimeric disintegrin that modulates the adhesion, motility, and invasiveness of integrin-expressing tumor cells. When formulated as a pharmaceutically acceptable composition, these proteins can be utilized to treat patients by inhibiting or disrupting disease processes associated with integrin binding to αvβ3 or αvβ5 integrins.

Career Highlights

Matthew Ritter is affiliated with the University of Southern California, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential impact on cancer therapies and patient outcomes.

Collaborations

Ritter collaborates with notable professionals in his field, including Francis S Markland, Jr. Their combined expertise contributes to the development of groundbreaking treatments and enhances the research environment at their institution.

Conclusion

Matthew Ritter's contributions to biomedical innovation, particularly through his patents and research at the University of Southern California, highlight his commitment to improving cancer treatment. His work exemplifies the importance of innovation in addressing complex medical challenges.